ROCK2 and cancer: Ultimately, our innovative framework offers a promising solution for the development of targeted ROCK2 inhibitors, which could play a crucial role in mitigating the progression of diseases associated with ROCK2 dysregulation, such as cancer metastasis, cardiovascular disorders, and neurodegenerative conditions.